SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ONXX -- Ignore unavailable to you. Want to Upgrade?


To: Boplicity who wrote (540)8/9/2000 10:52:51 AM
From: Paul Kern  Read Replies (1) | Respond to of 810
 
I have a friend, jack, who is pretty secretive about his investments but he likes some NAZ small cap stocks and some BB stocks. They all drop and a couple have gone to the pink sheets.

He'll say that he's found this stock that was selling for 125 and is now under five dollars and isn't a great investment because it has no place to but up.

His broker tells him that it's a special deal and don't tell anyone or he'll blow the deal that's in the works and Jack believes it. If only he would tell me what he's buying....

He did tell me about SchickTech at 20 and like a fool, I didn't short that piece of shit. It is really on the pink sheets, if not bankrupt, and gone.I don't bother upsetting myself by checking anymore.

Paul



To: Boplicity who wrote (540)8/10/2000 9:19:10 PM
From: Elmer  Read Replies (1) | Respond to of 810
 
OT,
Greg, Imclone Systems (IMCL) is seeking expedited approval of their head and neck cancer drug based on the results of their phase II trials. From reading the Yahoo board, it appears they are meeting with the FDA tomorrow and analysts later.

If they get expedited approval, one might think that ONXX could also.